Walker David B.
Known title: DirectorCIK: 0002081636
Walker David B.'s purchase track record
Walker David B. has only 1 open-market purchase with a full 6 months of price history after it -- too few to call a track record yet.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 3/13/2026 | DCH | $182K | +22.6% | +25.1% | +15.4% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Transaction History
| DCH | ▲ Buy | Grant | 29,773 | $0 | 4/30/2026 | View on chart |
| DCH | ▲ Buy | Open Market | 35,000 | $182K | 3/13/2026 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 14, 2026
Dauch names new CFO, faces lower price targets from Barclays and UBS
Dauch Corporation announced a financial leadership change, appointing Nathan Iles as CFO effective December 1 to succeed Christopher May. This executive shift coincides with recent analyst actions, as both Barclays and UBS lowered their price targets to $8 while maintaining their respective ratings. The stock has experienced a significant decline since February, currently trading near its 52-week low, which has prompted discussions about potential undervaluation despite the recent downward revisions.
Dauch names new CFO, faces lower price targets from Barclays and UBS. Dauch Corporation announced a financial leadership change, appointing Nathan Iles as CFO effective December 1 to succeed Christopher May. This executive shift coincides with recent analyst actions, as both Barclays and UBS lowered their price targets to $8 while maintaining their respective ratings. The stock has experienced a significant decline since February, currently trading near its 52-week low, which has prompted discussions about potential undervaluation despite the recent downward revisions.